|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human PSG6 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG13808-G-F|
|Human PSG6 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG13808-G-H|
|Human PSG6 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG13808-G-M|
|Human PSG6 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG13808-G-N|
|Human PSG6 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG13808-G-Y|
PSG6 is a pregnancy-specific glycoprotein(PSG). PSGs are secreted proteins which are produced by the rodent and primate placenta and play a critical role in pregnancy success. The levels of PSGs are highest during the third trimester of pregnancy, a time marked by the most profound suppression of MS disease attacks. PSGs regulate T-cell function. The regulation of T-cell function during pregnancy is likely the result of significant hormonal changes and may well involve immunoregulatory proteins derived from the placenta. Pregnancy specific glycoproteins (PSGs) are the most abundant placentally derived glycoproteins in the maternal serum. PSG1, PSG6, PSG6N, and PSG11 induce dose-dependent secretion of anti-inflammatory cytokines by human monocytes. Human and murine PSGs exhibit cross-species activity.